Translational Development Acquisition Corp.
Translational Development Acquisition Corp.（TDAC）股票概览
关键指标与盈利、估值、营收、股息等标签页深链。
FMP · TDAC · 截至 Jun 8, 2026
关键指标
探索 Translational Development Acquisition Corp. 数据
tdac stock data · financials财务快照
完整财报分析师评级与目标价
完整预测合计: 1 · 买入占比: 100.0%
竞争对手与同行
tdac competitorsTDAC
CEP
CEPO
FACT
HCMA
MACI股票表现
完整历史关于 Translational Development Acquisition Corp.
Translational Development Acquisition Corp. founded in 2022 and headquartered in New York, New York, currently conducts no significant business operations. Its primary goal is to complete a business …
what is translational development acquisition corp. · tdac stock overview · translational development acquisition corp. company profile · who is translational development acquisition corp. ceo · tdac NASDAQ · translational development acquisition corp. headquarters · translational development acquisition corp. business segments
关于股票概览与关键数据
Translational Development Acquisition Corp.（TDAC）是 Shell Companies 行业的 Financial Services 类公司，于 Feb 20, 2025 在 NASDAQ 上市。截至最近交易日，TDAC 股价为 $10.76，市值约为 $235.7M。过去12个月累计回报 +5.39%，年初至今回报 +2.57%。
根据 1 位华尔街分析师，Translational Development Acquisition Corp. 股票共识评级为Buy，12个月平均目标价为 $—。2025 财年 Translational Development Acquisition Corp. 营收 —，净利润 $6.4M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。
常见问题
截至最近一个交易日，Translational Development Acquisition Corp.（TDAC）股价为 $10.76，在 NASDAQ 上市，52周区间为 $10.21 – $10.80。